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We report five patients with variceal hemorrhage, in
three cases secondary to diffuse thrombosis of the
portal, superior mesenteric and splenic veins. Mes-
enteric angiography demonstrated patency of the
inferior mesenteric vein (IMV) in each, and success-
ful portal decompression by anastomosis of the IMV
to the left renal vein (n=4) or the inferior vena cava
(n=l) was accomplished. Bleeding was permanently
controlled: four patients have survived from one to
eight years post-operatively. Because shunt proce-
dures utilizing the IMV are technically straightfor-
ward, subtotally decompress the portal system and
avoid the right upper quadrant, they may be
advantageous in certain clinical settings.
Keywords: Mesenteric venous thrombosis, portal hyperten-
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INTRODUCTION
No single operative treatment is optimal for
variceal hemorrhage arising from portal hyper-
tension. Standard portacaval shunts reliably
control recurrent variceal hemorrhage, but may
be accompanied by an unacceptably high risk of
post-shunt encephalopathy [1, 2]. Further, a later
attempt at liver transplantation may be compli-
cated by the adhesions and anatomic distortion
resulting from the prior right upper quadrant
operation [3-5]. Selective shunts avoid the hilum
of the liver but have a higher risk of variceal
rebleeding [6] and may result in portal vein
thrombosis [7]. Occasionally, diffuse splanchnic
venous thrombosis [8, 9] thwarts consideration of
any conventional shunting procedure.
In several such clinical settings we have been
successful in utilizing the inferior mesenteric
vein (IMV) as a portal decompressive conduit.
The operative procedure is technically straight-
forward, appears to provide reliable reduction
of portal pressure, avoids post-shunt neurologic
complications, and could be advantageous in
patients who may later be candidates for liver
transplantation.
CASE REPORTS
Patient 1. A thirty-four year old woman with
massive recurrent upper gastrointestinal hemor-
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rhage, endoscopically seen to arise from gastric
varices, was referred for definitive care. She had
biopsy-proven post-necrotic cirrhosis. Splanch-
nic angiography demonstrated a large IMV.
Because of the patient’s youth she was deemed
to be a future liver transplant candidate, so a
shunt procedure which avoided the right upper
quadrant was felt warranted.
Exploration confirmed a patent IMV which
accepted a 7mm probe. The IMV was anasto-
mosed side-to-side to the ventral surface of the
left renal vein, after which a strong thrill could
be palpated in the inferior wall of the renal vein.
A pressure gradient of 8mm Hg was measured
between the splenic vein and the left renal vein.
Post-operative angiography and duplex sono-
graphy [10] confirmed shunt patency, and the
patient remains well, without evidence for
encephalopathy or rerurrent gastrointestinal
hemorrhage, at 4 years follow-up.
Patient 2. A forty-six year old man was re-
ferred because of variceal hemorrhage. At age 24
the onset of massive upper gastrointestinal
hemorrhage had led to the diagnosis of variceal
bleeding secondary to diffuse splanchnic venous
thrombosis, and he underwent resection of the
gastric cardia with interposition of an isoperistal-
tic segment of jejunum [11]. He had no further
evidence for gastrointestinal hemorrhage or liver
disease for twenty-two years. He then suffered
several episodes of hematemesis and upper
endoscopy demonstrated large esophageal and
gastric varices. Splanchnic angiography con-
firmed the diagnosis of diffuse thrombosis of the
portal, superior mesenteric, and splenic veins, but
he was noted to have a moderate-sized (5mm)
IMV. Abdominal exploration confirmed a patent
IMV: this was anastomosed to the left renal vein
using an interposed saphenous vein graft. Endo-
scopic examination oneweek and four years post-
operatively demonstrated 1+ esophageal varices
and no gastric varices; he has had no further
upper gastrointestinal hemorrhage at 12 years
follow-up.
Patient 3. A 39-year old man had massive
recurrent bleeding from esophageal and gastric
varices due to alcoholic cirrhosis. Considered a
potential liver transplantation candidate, he
required urgent portal decompression. Splanch-
nic angiography demonstrated a 6mm IMV; he
underwent an uneventful IMV-left renal vein
anastomosis with satisfactory portal decom-
pression (corrected splenic collateral vein pres-
sure 12mm Hg) and no further bleeding.
However, post-operatively he developed fulmi-
nant hepatic failure and expired on the 20th
post-operative day while awaiting liver trans-
plantation.
Patient 4. A 56-year old man had undergone
an unknown procedure-probably a mesocaval
shunt-15 years previously to treat bleeding
esophageal varices. Abstinent from alcohol for
more than a decade, he presented with variceal
hemorrhage which recurred despite several
sessions of endoscopic sclerotherapy. Splanch-
nic angiography revealed portal and superior
mesenteric vein thrombosis, a patent splenic
vein, and a large IMV. Side-to-side anastomosis
of the IMV to the inferior vena cava was
performed without complication. No further
bleeding occurred, and upper endoscopy at one
and three years showed stable 1+ esophageal
varices.
Patient 5. A 55-year old man was referred
following massive rectal bleeding, seen on
sigmoidoscopy to be arising from hemorrhoi-
dal varices. Splanchnic angiography demon-
strated an occluded portal, splenic, and
superior mesenteric vein but a large and
patent IMV. Coagulation workup revealed
anti-thrombin III deficiency [9]. A side-to-side
IMV-left renal vein anastomosis was per-
formed. Duplex scan at 3 days and 6 months
demonstrated a patent inferior mesorenal
shunt. No further rectal bleeding has occurred
at 5 years follow-up: the patient has been
maintained on warfarin to treat his prothrom-
botic state.INFERIOR MESENTERIC VEIN 367
COMMENT
Optimal surgical therapy for variceal hemor-
rhage depends on the procedure’s urgency, the
possibility of future liver transplantation, and
the patency of the various splanchnic veins.
Standard portacaval shunt procedures are
highly effective at halting variceal hemorrhage,
but have a substantial risk [30-80% [1,2]] of
post-shunt neurologic complications, and in
addition result in scarring and anatomic distor-
tion in the right upper quadrant-a handicap if a
subsequent liver transplantation is contemplated
[3-5]. Various selective shunts-most notably
the distal splenorenal shunt [12]-confer reason-
able protection against further variceal bleeding,
but are encumbered with numerous clinical
contraindications and ever more complex tech-
nical considerations [13]. At least 10% of such
patients will suffer portal vein thrombosis [7],
thereby markedly complicating subsequent liver
transplantation. Further, when compared to
standard portacaval shunts in properly-de-
signed prospective randomized trials [14], selec-
tive shunts do not provide definitive protection
against post-shunt neurologic complications,
especially in that majority of Western patients
who are alcoholics [15].
Other operative procedures to prevent vari-
ceal bleeding, most notably various forms of
esophagogastric devascularization as popular-
ized by Sugiura [16], have had excellent results
in Japan, but these have not been confirmed
either in Western Europe or in North America.
Use of IMV for portal decompression has been
reported sporadically in the past [17-20]-most
commonly in patients is whom diffuse splanch-
nic venous thrombosis [8, 9] interdicted standard
shunt procedures, or in patients in whom prior
splenectomy prevented the performance of
distal splenorenal shunt [20]. These indications
remain relevant, but we have resurrected the
IMV shunt because of two newer additional
considerations development of the concept of
partial portal decompression and the maturation of
liver transplantation as a clinically feasible man-
agement of patients with liver disease and
variceal hemorrhage.
A body of recent experimental [21] and
clinical [22-24] data suggest that, in comparison
to total shunts, procedures which only partially
decompress the portal system may result in
a lesser risk of post-shunt liver failure and
neurologic deterioration. Some investigators
suggest that this beneficial effect results from
continued prograde portal flow [24], consonant
with the "selectivity" principle originally char-
acterized by Warren [12]. Other studies, how-
ever, suggest that the protective effect of partial
portal decompression is due to diminished
intestinal neurotoxin absorption in the presence
of residual mesenteric venous hypertension
[21,22]. Regardless, shunts which only partially
decompress the portal system appear to result in
a lower risk of post-shun[ morbidity and
mortality [22-24]. This principle has been
applied to the concept of transjugular intrahe-
patic portacaval shunting (TIPS), a nonsurgical
transcatheter technique in which a 10mm Hg
post-shunt gradient between portal vein and
supra-hepatic inferior vena cava is considered
optimal [26].
The increasing availibility of liver transplanta-
tion to treat end-stage liver disease means that
certain variceal bleeders treated by shunt opera-
tions may later be transplant candidates [3].
While prior performance of a standard portaca-
val shunt is no longer an absolute contraindica-
tion to liver transplantation [25], the scarring
and anatomic distortion from such procedures
undoubtedly complicate the performance of
subsequent liver replacement [3-5]. Conse-
quently, the recommendation has been made
that any such patient who might later require
liver transplantation should undergo either
mesocaval [27] or distal splenorenal shunts
[4,5]. Because the former procedure has a
substantial rate of graft thrombosis and recur-368 P. GORINI AND K. JOHANSEN
rent variceal bleeding [28], and the latter
procedure is technically taxing [13] and has
multiple contraindications [29], an alternative
shunt option would be very helpful. In certain
patients TIPS may be an option: however, this
procedure is not durable and may have sub-
stantial complications [30,31], sometimes neces-
sitating operative portal decompression [31]. We
view the IMV shunt as a rational alternative in
such patients.
An important feature favoring the use of the
IMV for portal decompression is its technical ease.
Because of the proximity of the IMV and the left
renal vein the IMV shunt may be the most
technically straightforward of all portal decom-
pressive procedures. The IMV dilates in portal
hypertension [17], frequently to 5-6mm in
diameter and even more in certain conditions of
diffuse splanchnic venous thrombosis where it
may remain the only patent mesenteric outflow
vessel [17-19]. Second, the procedure is per-
formed entirely on the left side of the mesentery,
leaving the right upper quadrant inviolate-
useful if future orthotopic liver transplantation
is contemplated. Third, because it is an exemplary
"small-stoma" shunt, it only partially decom-
presses the portal system and should confer
maximal protection against post-shunt encepha-
lopathy [21-24]. Finally (particularly if the
procedure is performed as an inferior mesocaval
anastomosis, as in our Patient #4) excellent
angiographic access to the coronary veins for
subsequent embolization may be possible [32].
While longer follow-up of a larger group of
patients is required to discern whether use of the
IMV as a portal decompressive conduit provides
longterm protection against variceal rebleeding
and post-shunt neurologic complications, our
experience suggests that it is a technically
straightforward procedure with good short-term
function. It may offer therapeutic advantages in
selected patients with variceal hemorrhage who
require portal decompression.
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COMMENTARY
The authors resurrect an interesting but techni-
cally simple portosystemic shunt, namely, the
inferior mesenteric vein to renal vein or vena
caval shunt. The authors draw attention to
reports from the 1960’s and 1970’s about the
use of this shunt. They have used it in 5 patients
with moderately long-term success in 4. They
advocate this shunt for patients with diffuse
splanchnic venous thrombosis and also for
patients who are potential liver transplant
candidates.
It needs to be recognized that the role of the
inferior mesenteric vein shunt is as yet unproven,
despite earlier reports and the present paper.
However, it is a useful alternative to be kept in
mind for a difficult patient situation. I do not
believe that this shunt is justified in patients who
are likely to be transplant candidates and who
have an otherwise suitable portal venous system
for a standard distal splenorenal shunt or a Sarfeh
narrow-diameter PTFE shunt (this latter being
placed from the mesenteric vein to the vena cava
rather than in the standard portacaval position).
However, in patients with diffuse splanchnic
venous thrombosis, if the inferior mesenteric vein
is patent, it seems a reasonable alternative in
endoscopic failures. The authors have also used
the procedure in one patient with uncontrollable
rectal haemorrhage from anorectal varices. This
could also be an important indication.
Our group’s current view is that endoscopic
therapy is the primary treatment of choice for
acute bleeding varices. We agree with the shift
that is occurring to variceal banding or a
combination of banding and sclerotherapy from
the previously widely used pure sclerotherapy
techniques [1]. We define failures as patients
who have two further bleeds after endoscopic
management during a single hospital admission
for acute variceal bleeding. We currently submit
such patients to an emergency TIPS procedure.
It should be noted that this is rarely undertaken,
because the percentage of patients failing endo-
scopic therapy in our institution is currently
very low [2]. If a patient with diffuse splanchnic
venous thrombosis, including portal vein throm-
bosis was to fail endoscopic therapy, then the
authors’ suggestion of a surgical inferior mesen-
teric vein shunt, if this vein is patent and
enlarged, seems reasonable.370 P. GORINI AND K. JOHANSEN
We currently advocate either the distal sple-
norenal shunt or the narrow diameter PTFE
shunt of Sarfeh [3] for the failures of endoscopic
therapy in long-term management after a vari-
ceal bleed.
[3] Sarfeh, I. J., Rypins, E. B. (1994). Partial versus total
portacaval shunt in alcoholic cirrhosis. Results of a
prospective, randomized clinical trial. Annals of Surgery,
219, 353- 361.
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